BIIB

Biogen Idec Inc. News Headlines

$290.54
*  
0.94
 negative 
0.32%
Get BIIB Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Breakthrough Status for Glaxo Candidate - Analyst Blog
6/28/2013 5:20:01 PM - Zacks.com

Data on Acorda Pipeline Candidate - Analyst Blog
6/27/2013 4:32:52 PM - Zacks.com

Integra Grows European Portfolio - Analyst Blog
6/27/2013 2:30:57 PM - Zacks.com

Celgene Inks Oncology Deal - Analyst Blog
6/27/2013 11:31:58 AM - Zacks.com

Affymetrix Upgraded to Neutral - Analyst Blog
6/26/2013 4:30:23 PM - Zacks.com

Celgene presents Revlimid Data - Analyst Blog
6/26/2013 11:30:01 AM - Zacks.com

Isis Pharma Up on Phase II Data - Analyst Blog
6/25/2013 7:15:01 PM - Zacks.com

Positive Data on Infinity's Oncology Candidate - Analyst Blog
6/25/2013 6:15:01 PM - Zacks.com

AstraZeneca/BMY Present Forxiga Data - Analyst Blog
6/24/2013 5:30:01 PM - Zacks.com

SGEN/Takeda Report Data on Adcetris - Analyst Blog
6/21/2013 5:30:01 PM - Zacks.com

Another Setback for Idenix - Analyst Blog
6/21/2013 5:15:01 PM - Zacks.com

Draft Guidance from NICE for pSivida's Iluvien - Analyst Blog
6/21/2013 4:31:54 PM - Zacks.com

Pluristem Updates on IC Study - Analyst Blog
6/20/2013 6:08:01 PM - Zacks.com

AstraZeneca and BMY Drug Disappoints - Analyst Blog
6/20/2013 5:30:30 PM - Zacks.com

Glaxo Gets Offer for Thrombosis Drugs - Analyst Blog
6/19/2013 5:32:30 PM - Zacks.com

DaVita and Myriad Join Forces - Analyst Blog
6/18/2013 6:25:01 PM - Zacks.com

Perrigo in Expansion Mode - Analyst Blog
6/18/2013 12:10:01 PM - Zacks.com

J&J to Buy Aragon for $1 Billion - Analyst Blog
6/18/2013 11:30:40 AM - Zacks.com

Good News for Celgene's Pipeline - Analyst Blog
6/18/2013 11:30:01 AM - Zacks.com

Teva to Acquire MicroDose Therapeutx - Analyst Blog
6/18/2013 11:29:38 AM - Zacks.com

Amgen Xgeva Label Expanded - Analyst Blog
6/17/2013 4:32:18 PM - Zacks.com

Elan Explores Sale Options - Analyst Blog
6/17/2013 4:30:29 PM - Zacks.com

Myriad: End to Legal Battle over Patents - Analyst Blog
6/17/2013 2:30:39 PM - Zacks.com

Elan Shareholders Bring Management To Heel
6/17/2013 1:40:00 PM - Investopedia

Good News for Celgene's Revlimid - Analyst Blog
6/17/2013 11:31:15 AM - Zacks.com